SCHEMBL31300992

SCHEMBL31300992

Cc1ccc(-c2cc(C)c3cc(Oc4c(Cl)cc(-n5nc(C#N)c(=O)[nH]c5=O)cc4Cl)ccc3n2)nc1

nearest known ligand 0.46

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
THRB P10828 19/20 0.46
THRA P10827 15/20 0.46
CYP2C8 P10632 1/20 0.46
CYP2C9 P11712 1/20 0.46
NPC1 O15118 1/20 0.34
ALDH1A1 P00352 1/20 0.34
LMNA P02545 1/20 0.34
MAPT P10636 1/20 0.34
OPRK1 P41145 1/20 0.34
HTT P42858 1/20 0.34
RAB9A P51151 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25768400 0.94 THRB (0.46) THRBTHRACYP2C8CYP2C9NPC1
SCHEMBL31301037 0.94 THRB (0.46) THRBTHRACYP2C8CYP2C9NPC1
SCHEMBL31301014 0.92 THRA (0.45) THRBTHRACYP2C8CYP2C9NPC1
SCHEMBL25768397 0.92 THRA (0.45) THRBTHRACYP2C8CYP2C9NPC1
SCHEMBL25768404 0.92 THRB (0.45) THRBTHRACYP2C8CYP2C9NPC1
SCHEMBL31301029 0.92 THRB (0.45) THRBTHRACYP2C8CYP2C9NPC1
SCHEMBL25768396 0.89 THRB (0.46) THRBTHRACYP2C8CYP2C9NPC1
SCHEMBL30460742 0.89 THRB (0.46) THRBTHRACYP2C8CYP2C9NPC1
SCHEMBL25245194 0.88 THRB (0.44) THRBTHRACYP2C8CYP2C9
SCHEMBL30460685 0.88 THRB (0.44) THRBTHRACYP2C8CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4458820-A1 CLASS OF QUINOLINE COMPOUNDS, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION AND USE THEREOF Shanghai Institute of Materia Medica, Chinese Academy of Sciences (CN) 2024-11-06 EP claimed
EP-4458820-A1 CLASS OF QUINOLINE COMPOUNDS, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION AND USE THEREOF Shanghai Institute of Materia Medica, Chinese Academy of Sciences (CN) 2024-11-06 EP disclosed